Tezepelumab Cuts Exacerbations in Severe, Uncontrolled Asthma

THURSDAY, May 13, 2021 -- Patients with severe, uncontrolled asthma receiving tezepelumab have fewer exacerbations than those receiving placebo, according to a study published in the May 13 issue of the New England Journal of Medicine. Andrew...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news